Jim Cramer Says "I'm a Eli Lilly Guy" When Asked About Viking Therapeutics

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer discussed, along with recent market rotation. When a caller asked about the stock, here’s what Cramer had to say in response:

“Okay, no, look, I’m a Eli Lilly guy, okay? I’m going to stick with it. If I’m going to do Viking, I’m going to do Viking Cruises, right? VIK. That’s the one you want to own, I mean, of the Vikings.”

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders. A caller made a note of their long-term position in the stock during the episode aired on November 4, 2025, and mentioned that the caller has been observing Novo Nordisk and Pfizer’s bidding war for Metsera. Cramer responded:

“Yeah, I know, and I’ve watched that, and I don’t, I think that Viking would’ve gotten a bid if it didn’t get it yet. I know people are expecting whoever loses in that war that you just mentioned is going to buy Viking. I tell you what, you should buy. You own Eli Lilly. That’s been the winner. The trust owns it. I really like it a lot.”

While we acknowledge the potential of VKTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.